| Entry |
|
|---|
| Name |
Interferon gamma-1b (USAN/INN);
Actimmune (TN) |
|---|
| Product |
|
|---|
| Formula |
C734H1166N204O216S5
|
|---|
| Exact mass |
16454.513
|
|---|
| Mol weight |
16464.674
|
|---|
| Sequence |
MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN
FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE
LSPAAKTGKR KRSQMLFRGR |
|---|
| Type |
Peptide |
|---|
| Class |
Immunological agent
DG01752 Interferone
|
|---|
| Remark |
| Product (DG00737): | D00747<US> D03357<JP> |
|
|---|
| Efficacy |
Antineoplastic, Immunomodulator, Biological response modifier |
|---|
| Disease |
Chronic granulomatous disease [DS: H00098] Malignant osteopetrosis [DS: H00436] |
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
| hsa04650 | Natural killer cell mediated cytotoxicity |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AB Interferons
L03AB03 Interferon gamma
D00747 Interferon gamma-1b (USAN/INN) <US>
USP drug classification [BR:br08302]
Immunological Agents
Immunostimulants
Interferons
Interferon Gamma 1b
D00747 Interferon gamma-1b (USAN/INN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG00737 Interferon gamma
D00747 Interferon gamma-1b
Drug classes [BR:br08332]
Immunological agent
DG01752 Interferone
D00747 Interferon gamma-1b
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interferon receptors
IFNGR1 (CD119)
D00747 Interferon gamma-1b (USAN/INN) <US>
IFNGR2
D00747 Interferon gamma-1b (USAN/INN) <US>
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG00737 Interferon gamma
|
|---|
| Other DBs |
|
|---|
